Cancer Research
Degarelix vs Goserelin Head-to-Head in Advanced Prostate Cancer
Phase 3 trial pits next-gen GnRH antagonist degarelix against standard goserelin in prostate cancer hormone suppression.
Clinical Trial
Jul 2, 2026 0
Topic
Cancer
Latest breakthroughs in cancer research, treatment, and prevention
640 articles
Cancer Research
Senescent Non-Cancer Cells Inside Tumors Are Reshaping Cancer Outcomes
A new review reveals how senescent healthy cells within tumors quietly drive cancer progression and therapy resistance.
Review
Jul 2, 2026 0
Cancer Research
Accelerated Biological Aging May Drive the Surge in Early-Onset Cancer
New research links faster biological aging in younger adults to the alarming rise in cancers before age 50.
Research Paper
Jul 2, 2026 0
Cancer Research
Abraxane Plus Pembrolizumab Targets Advanced Bladder Cancer in Cisplatin-Ineligible Patients
A completed phase 2 trial tested nab-paclitaxel combined with the checkpoint inhibitor pembrolizumab in patients with advanced urothelial cancer who cannot tolerate cisplatin.
Clinical Trial
Jul 1, 2026 0
Cancer Research
Low-Dose Gut Radiation Revives Immune Checkpoint Therapy in Drug-Resistant Cancers
A phase II trial tests whether 1Gy intestinal radiation can re-sensitize solid tumors that have stopped responding to immunotherapy.
Clinical Trial
Jul 1, 2026 0
Cancer Research
USC Scientists Grow Endless Cancer-Fighting Immune Cells From Self-Renewing Precursors
USC researchers unlocked a scalable supply of engineered immune-cell precursors that fight tumors and may revolutionize cancer immunotherapy.
Press Release
Jun 30, 2026 0
Cancer Research
New Compounds Force Pancreatic Cancer Cells to Self-Destruct by Overloading Their Own Signals
Experimental PCAI compounds blocked over 90% of pancreatic cancer cell migration and triggered self-destruction by hyperactivating tumor growth pathways.
Press Release
Jun 30, 2026 0
Cancer Research
Bevacizumab Added to Chemo Tested in Children With Metastatic Sarcoma
A Phase 2 trial examines whether adding the anti-angiogenic drug bevacizumab to standard chemo improves outcomes in pediatric sarcoma.
Clinical Trial
Jun 30, 2026 0
Cancer Research
GLP-1 Drug Breaks Liver Cancer's Drug Resistance via Metabolic Pathway
GLP-1 receptor agonists may overcome Lenvatinib resistance in hepatocellular carcinoma by targeting a key glycolytic vulnerability.
Research Paper
Jun 30, 2026 0
Cancer Research
A New Framework for Targeting Cancer's Hidden Ally: Tumor Fibroblasts
Researchers propose a unified model classifying cancer-associated fibroblasts by molecular phenotype and spatial location to guide precision therapy.
Review
Jun 30, 2026 0
Cancer Research
Stress Hormone Suppresses Anti-Tumor Immunity via Gut Bacteria Signaling
Corticosterone triggered by gut microbiome-derived phage DNA disables B cell tumor immunity, revealing a stress-cancer axis.
Research Paper
Jun 30, 2026 0
Cancer Research
Triple Combo Targets Chemotherapy-Resistant Pancreatic Cancer With Immune Boost
A phase I trial tests SD-101, nivolumab, and radiation together against metastatic pancreatic cancer that has stopped responding to chemo.
Clinical Trial
Jun 29, 2026 0